Loading...
Projects / Programmes
Detection of molecular alterations during head and neck carcinogenesis
Research activity
| Code | Science | Field | Subfield |
|---|---|---|---|
| 3.04.00 | Medical sciences | Oncology |
| Code | Science | Field |
|---|---|---|
| B200 | Biomedical sciences | Cytology, oncology, cancerology |
| B520 | Biomedical sciences | General pathology, pathological anatomy |
Keywords
Carcinogenesis, premalignant lesions, head and neck cancer, histology, immunohistochemistry, molecular pathology
Evaluation
(metodology)
Citations
Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
Organisations (2) , Researchers (14)
0312 University Medical Centre Ljubljana
| no. | Code | Name and surname | Research area | Role | Period | No. of publicationsNo. of publications |
|---|---|---|---|---|---|---|
| 1. | 07479 | Oncology | Researcher | 1997 - 1999 | 86 |
0381 University of Ljubljana, Faculty of Medicine
| no. | Code | Name and surname | Research area | Role | Period | No. of publicationsNo. of publications |
|---|---|---|---|---|---|---|
| 1. | 17954 | Researcher | 1999 | 0 | ||
| 2. | 17952 | Researcher | 1997 - 1999 | 0 | ||
| 3. | 05367 | Oncology | Researcher | 1999 | 194 | |
| 4. | 17953 | Researcher | 1998 - 1999 | 0 | ||
| 5. | 02273 | Microbiology and immunology | Researcher | 1999 | 533 | |
| 6. | 02127 | Oncology | Head | 1997 - 1999 | 409 | |
| 7. | 09275 | Chemistry | Researcher | 1999 | 572 | |
| 8. | 15472 | Oncology | Researcher | 1999 | 484 | |
| 9. | 17951 | Researcher | 1998 - 1999 | 1 | ||
| 10. | 17956 | Researcher | 1997 - 1999 | 15 | ||
| 11. | 18362 | Researcher | 1998 - 1999 | 8 | ||
| 12. | 15471 | Microbiology and immunology | Researcher | 1999 | 30 | |
| 13. | 12955 | Microbiology and immunology | Researcher | 1999 | 415 |
Abstract
The aim of our research is to define those phenotypical so as genetic characteristics of the squamous epithelium within the head and neck region, and particularly of the larynx, which manifest themselves as mutant proteins, numerical chromosome aberrations or gene mutations. Analysis of a large cohort of retrospectively and prospectively ascertained patients and their follow-up is expected to reveal reliable biomarkers important also for identification of high risk precancerous lesions that may progress to invasive cancer.